Literature DB >> 58307

Evidence of an agent transmissible from ulcerative colitis tissue.

D R Cave, D N Mitchell, B N Brooke.   

Abstract

Five New Zealand White rabbits were injected intracolonically with homogenates (100 mum) of ulcerative-colitis tissue. Histological changes closely similar to those seen in the human donors were present in the mucosa and submucosa of the large intestine of four of these rabbits 3-12 months later. Similar changes were seen in the large intestine of three of four rabbits 6-13 months after intravenous or intracolonic inoculation of homogenates of rabbit mesenteric lymph-nodes after passage of human ulcerative colitis tissue (100 mum or 0.2 mum). Three of thirty A2G strain mice injected with similar tissue homogenates (100 mum or 0.2 mum) from patients with ulcerative colitis into the footpad or intraperitoneally, had granulomatous changes in footpad, bowel, liver and/or spleen 3-22 months later. Such changes did not develop in rabbits or mice inoculated with tissue from normal controls. The results of these experiments suggest that a transmissible factor is involved in the aetiology of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58307     DOI: 10.1016/s0140-6736(76)92649-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.

Authors:  L Manzano; M Alvarez-Mon; L Abreu; J Antonio Vargas; E de la Morena; F Corugedo; A Duràntez
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Evidence for a transmissible factor in Crohn's disease.

Authors:  B J Donnelly; P V Delaney; T M Healy
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

Review 3.  Escherichia coli and ulcerative colitis.

Authors:  D Burke
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

Review 4.  Ulcerative colitis and Crohn's colitis: differential diagnosis and treatment.

Authors:  T C Northfield
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

5.  Circulating immune complexes in ulcerative colitis. I. Correlation to disease activity.

Authors:  H Nielsen; V Binder; H Daugharty; S E Svehag
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

6.  Alteration in T lymphocyte subpopulations in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

Review 7.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

8.  Rectal IgE cells in inflammatory bowel disease.

Authors:  D P O'Donoghue; P Kumar
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

9.  Search for evidence of a viral aetiology for inflammatory bowel disease.

Authors:  H H Yoshimura; M K Estes; D Y Graham
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

10.  Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn's disease. A preliminary report.

Authors:  H J Van Kruiningen; R J Chiodini; W R Thayer; J A Coutu; R S Merkal; P L Runnels
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.